Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 443

1.

Human Proteome Project Mass Spectrometry Data Interpretation Guidelines 3.0.

Deutsch EW, Lane L, Overall CM, Bandeira N, Baker MS, Pineau C, Moritz RL, Corrales F, Orchard S, Van Eyk JE, Paik YK, Weintraub ST, Vandenbrouck Y, Omenn GS.

J Proteome Res. 2019 Oct 21. doi: 10.1021/acs.jproteome.9b00542. [Epub ahead of print]

PMID:
31599596
2.

Statin Use and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.

Goh MJ, Sinn DH, Kim S, Woo SY, Cho H, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Hepatology. 2019 Sep 25. doi: 10.1002/hep.30973. [Epub ahead of print]

PMID:
31556128
3.

Use of cyclooxygenase inhibitor and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nested case-control study using a nationwide population-based data.

Cho KS, Sohn W, Lee YC, Chi SA, Cho JY, Kim K, Paik YH.

J Viral Hepat. 2019 Sep 10. doi: 10.1111/jvh.13201. [Epub ahead of print]

PMID:
31505085
4.

Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network.

Lee JH, Joo I, Kang TW, Paik YH, Sinn DH, Ha SY, Kim K, Choi C, Lee G, Yi J, Bang WC.

Eur Radiol. 2019 Sep 2. doi: 10.1007/s00330-019-06407-1. [Epub ahead of print]

PMID:
31478087
5.

Progress on Identifying and Characterizing the Human Proteome: 2019 Metrics from the HUPO Human Proteome Project.

Omenn GS, Lane L, Overall CM, Corrales FJ, Schwenk JM, Paik YK, Van Eyk JE, Liu S, Pennington S, Snyder MP, Baker MS, Deutsch EW.

J Proteome Res. 2019 Sep 13. doi: 10.1021/acs.jproteome.9b00434. [Epub ahead of print]

PMID:
31430157
6.

Ascaroside Pheromones: Chemical Biology and Pleiotropic Neuronal Functions.

Park JY, Joo HJ, Park S, Paik YK.

Int J Mol Sci. 2019 Aug 9;20(16). pii: E3898. doi: 10.3390/ijms20163898. Review.

7.

FusionPro, a Versatile Proteogenomic Tool for Identification of Novel Fusion Transcripts and Their Potential Translation Products in Cancer Cells.

Kim CY, Na K, Park S, Jeong SK, Cho JY, Shin H, Lee MJ, Han G, Paik YK.

Mol Cell Proteomics. 2019 Aug;18(8):1651-1668. doi: 10.1074/mcp.RA119.001456. Epub 2019 Jun 17.

PMID:
31208993
8.

Liver disease-associated keratin 8 and 18 mutations modulate keratin acetylation and methylation.

Jang KH, Yoon HN, Lee J, Yi H, Park SY, Lee SY, Lim Y, Lee HJ, Cho JW, Paik YK, Hancock WS, Ku NO.

FASEB J. 2019 Aug;33(8):9030-9043. doi: 10.1096/fj.201800263RR. Epub 2019 Jun 14.

PMID:
31199680
9.

Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea.

Kim J, Kang W, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Korean J Intern Med. 2019 Jun 17. doi: 10.3904/kjim.2018.040. [Epub ahead of print]

10.

Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia.

Kim TS, Sinn DH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

J Gastroenterol Hepatol. 2019 Jun 3. doi: 10.1111/jgh.14750. [Epub ahead of print]

PMID:
31157456
11.

Toward Completion of the Human Proteome Parts List: Progress Uncovering Proteins That Are Missing or Have Unknown Function and Developing Analytical Methods.

Paik YK, Overall CM, Corrales F, Deutsch EW, Lane L, Omenn GS.

J Proteome Res. 2018 Dec 7;17(12):4023-4030. doi: 10.1021/acs.jproteome.8b00885. No abstract available.

12.

Hepatic resection vs percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm.

Song KD, Lim HK, Rhim H, Lee MW, Kang TW, Paik YH, Kim JM, Joh JW.

World J Gastrointest Oncol. 2019 Mar 15;11(3):227-237. doi: 10.4251/wjgo.v11.i3.227.

13.

Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?

Kim J, Sinn DH, Choi MS, Kang W, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW.

PLoS One. 2019 Mar 7;14(3):e0213547. doi: 10.1371/journal.pone.0213547. eCollection 2019.

14.

Prognostic potential of the preoperative plasma complement factor B in resected pancreatic cancer: A pilot study.

Kim SH, Lee MJ, Hwang HK, Lee SH, Kim H, Paik YK, Kang CM.

Cancer Biomark. 2019;24(3):335-342. doi: 10.3233/CBM-181847.

PMID:
30829612
15.

Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients.

Sinn DH, Choi GS, Park HC, Kim JM, Kim H, Song KD, Kang TW, Lee MW, Rhim H, Hyun D, Cho SK, Shin SW, Jeong WK, Kim SH, Yu JI, Ha SY, Lee SJ, Lim HY, Kim K, Ahn JH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Joh JW, Lim HK, Paik SW.

PLoS One. 2019 Jan 14;14(1):e0210730. doi: 10.1371/journal.pone.0210730. eCollection 2019.

16.

The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis.

Park S, In Hwang S, Kim J, Hwang S, Kang S, Yang S, Kim J, Kang W, Kim KH, Han DW, Paik YH.

Stem Cell Res Ther. 2019 Jan 11;10(1):21. doi: 10.1186/s13287-018-1127-3.

17.

200+ Protein Concentrations in Healthy Human Blood Plasma: Targeted Quantitative SRM SIS Screening of Chromosomes 18, 13, Y, and the Mitochondrial Chromosome Encoded Proteome.

Kopylov AT, Ponomarenko EA, Ilgisonis EV, Pyatnitskiy MA, Lisitsa AV, Poverennaya EV, Kiseleva OI, Farafonova TE, Tikhonova OV, Zavialova MG, Novikova SE, Moshkovskii SA, Radko SP, Morukov BV, Grigoriev AI, Paik YK, Salekdeh GH, Urbani A, Zgoda VG, Archakov AI.

J Proteome Res. 2019 Jan 4;18(1):120-129. doi: 10.1021/acs.jproteome.8b00391. Epub 2018 Dec 11.

PMID:
30480452
18.

ASV-ID, a Proteogenomic Workflow To Predict Candidate Protein Isoforms on the Basis of Transcript Evidence.

Jeong SK, Kim CY, Paik YK.

J Proteome Res. 2018 Dec 7;17(12):4235-4242. doi: 10.1021/acs.jproteome.8b00548. Epub 2018 Oct 15.

PMID:
30289715
19.

Launching the C-HPP neXt-CP50 Pilot Project for Functional Characterization of Identified Proteins with No Known Function.

Paik YK, Lane L, Kawamura T, Chen YJ, Cho JY, LaBaer J, Yoo JS, Domont G, Corrales F, Omenn GS, Archakov A, Encarnación-Guevara S, Lui S, Salekdeh GH, Cho JY, Kim CY, Overall CM.

J Proteome Res. 2018 Dec 7;17(12):4042-4050. doi: 10.1021/acs.jproteome.8b00383. Epub 2018 Nov 29.

20.

Identification of Missing Proteins in Human Olfactory Epithelial Tissue by Liquid Chromatography-Tandem Mass Spectrometry.

Hwang H, Jeong JE, Lee HK, Yun KN, An HJ, Lee B, Paik YK, Jeong TS, Yee GT, Kim JY, Yoo JS.

J Proteome Res. 2018 Dec 7;17(12):4320-4324. doi: 10.1021/acs.jproteome.8b00408. Epub 2018 Aug 20.

PMID:
30113170
21.

Progress on Identifying and Characterizing the Human Proteome: 2018 Metrics from the HUPO Human Proteome Project.

Omenn GS, Lane L, Overall CM, Corrales FJ, Schwenk JM, Paik YK, Van Eyk JE, Liu S, Snyder M, Baker MS, Deutsch EW.

J Proteome Res. 2018 Dec 7;17(12):4031-4041. doi: 10.1021/acs.jproteome.8b00441. Epub 2018 Aug 23. Review.

22.

Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy.

Song BG, Sinn DH, Chi S, Kim K, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1447-1452. doi: 10.1097/MEG.0000000000001226.

PMID:
30063482
23.

Effect of mirror therapy and electrical stimulation on upper extremity function in stroke with hemiplegic patient: a pilot study.

Paik YR, Lee JH, Lee DH, Park HS, Oh DH.

J Phys Ther Sci. 2017 Dec;29(12):2085-2086. doi: 10.1589/jpts.29.2085. Epub 2017 Dec 7.

24.

Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?

Kim KM, Kim J, Sinn DH, Kim HS, Kim K, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Scand J Gastroenterol. 2018 Jun;53(6):727-733. doi: 10.1080/00365521.2018.1458895. Epub 2018 Apr 3.

PMID:
29609485
25.

Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma.

Yu JI, Yoo GS, Cho S, Jung SH, Han Y, Park S, Lee B, Kang W, Sinn DH, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Park HC.

Radiat Oncol J. 2018 Mar;36(1):25-34. doi: 10.3857/roj.2017.00409. Epub 2018 Mar 29.

26.

Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.

Bae J, Sinn DH, Kang W, Gwak GY, Choi MS, Paik YH, Lee JH, Koh KC, Paik SW.

Liver Int. 2018 Aug;38(8):1442-1448. doi: 10.1111/liv.13732. Epub 2018 Mar 25.

PMID:
29495113
27.

Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization.

Kim JH, Sinn DH, Lee JH, Hyun D, Cho SK, Shin SW, Chang Y, Kim YJ, Yoon JH, Kang W, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Choi MS.

Dig Dis Sci. 2018 Apr;63(4):1062-1071. doi: 10.1007/s10620-018-4934-6. Epub 2018 Feb 13.

PMID:
29442276
28.

O-GlcNAcylation of the Tumor Suppressor FOXO3 Triggers Aberrant Cancer Cell Growth.

Shin H, Cha HJ, Na K, Lee MJ, Cho JY, Kim CY, Kim EK, Kang CM, Kim H, Paik YK.

Cancer Res. 2018 Mar 1;78(5):1214-1224. doi: 10.1158/0008-5472.CAN-17-3512. Epub 2018 Jan 4.

29.

Progress and Future Direction of Chromosome-Centric Human Proteome Project.

Paik YK, Overall CM, Deutsch EW, Van Eyk JE, Omenn GS.

J Proteome Res. 2017 Dec 1;16(12):4253-4258. doi: 10.1021/acs.jproteome.7b00734.

PMID:
29191025
30.

Effects of bedside self-exercise on oropharyngeal swallowing function in stroke patients with dysphagia: a pilot study.

Cho YS, Oh DH, Paik YR, Lee JH, Park JS.

J Phys Ther Sci. 2017 Oct;29(10):1815-1816. doi: 10.1589/jpts.29.1815. Epub 2017 Oct 21.

31.

Advances in the Chromosome-Centric Human Proteome Project: looking to the future.

Paik YK, Omenn GS, Hancock WS, Lane L, Overall CM.

Expert Rev Proteomics. 2017 Dec;14(12):1059-1071. doi: 10.1080/14789450.2017.1394189. Epub 2017 Nov 10. Review.

32.

Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma.

Hwang JA, Kang TW, Kim YK, Kim SH, Paik YH, Ha SY, Kim S.

Eur J Radiol. 2017 Oct;95:362-369. doi: 10.1016/j.ejrad.2017.08.036. Epub 2017 Aug 31.

PMID:
28987693
33.

Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.

Oh IS, Sinn DH, Kang TW, Lee MW, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Dig Dis Sci. 2017 Nov;62(11):3235-3242. doi: 10.1007/s10620-017-4775-8. Epub 2017 Oct 5.

PMID:
28983724
34.

Next Generation Proteomic Pipeline for Chromosome-Based Proteomic Research Using NeXtProt and GENCODE Databases.

Hwang H, Park GW, Park JY, Lee HK, Lee JY, Jeong JE, Park SR, Yates JR 3rd, Kwon KH, Park YM, Lee HJ, Paik YK, Kim JY, Yoo JS.

J Proteome Res. 2017 Dec 1;16(12):4425-4434. doi: 10.1021/acs.jproteome.7b00223. Epub 2017 Oct 13.

PMID:
28965411
35.

Systematic Proteogenomic Approach To Exploring a Novel Function for NHERF1 in Human Reproductive Disorder: Lessons for Exploring Missing Proteins.

Na K, Shin H, Cho JY, Jung SH, Lim J, Lim JS, Kim EA, Kim HS, Kang AR, Kim JH, Shin JM, Jeong SK, Kim CY, Park JY, Chung HM, Omenn GS, Hancock WS, Paik YK.

J Proteome Res. 2017 Dec 1;16(12):4455-4467. doi: 10.1021/acs.jproteome.7b00146. Epub 2017 Nov 1.

36.

Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial.

Yu JI, Park HC, Jung SH, Choi C, Shin SW, Cho SK, Sinn DH, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Sahinbas H, Paik SW.

Oncotarget. 2017 Apr 13;8(32):52651-52664. doi: 10.18632/oncotarget.17072. eCollection 2017 Aug 8.

37.

Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation.

Kim SS, Kang TW, Kim M, Lee MW, Cho SK, Paik YH, Kim MJ.

Clin Radiol. 2018 Feb;73(2):216.e1-216.e8. doi: 10.1016/j.crad.2017.07.020. Epub 2017 Aug 30.

PMID:
28859852
38.
39.

The genetic basis of natural variation in a phoretic behavior.

Lee D, Yang H, Kim J, Brady S, Zdraljevic S, Zamanian M, Kim H, Paik YK, Kruglyak L, Andersen EC, Lee J.

Nat Commun. 2017 Aug 17;8(1):273. doi: 10.1038/s41467-017-00386-x.

40.

MGL-1 on AIY neurons translates starvation to reproductive plasticity via neuropeptide signaling in Caenorhabditis elegans.

Jeong H, Paik YK.

Dev Biol. 2017 Oct 1;430(1):80-89. doi: 10.1016/j.ydbio.2017.08.014. Epub 2017 Aug 12.

41.

A conserved neuronal DAF-16/FoxO plays an important role in conveying pheromone signals to elicit repulsion behavior in Caenorhabditis elegans.

Park D, Hahm JH, Park S, Ha G, Chang GE, Jeong H, Kim H, Kim S, Cheong E, Paik YK.

Sci Rep. 2017 Aug 3;7(1):7260. doi: 10.1038/s41598-017-07313-6.

42.

The Application of REDOR NMR to Understand the Conformation of Epothilone B.

Lee JH, Kim MS, Lee HW, Lee IC, Kim HK, Kim ND, Lee S, Seo H, Paik Y.

Int J Mol Sci. 2017 Jul 9;18(7). pii: E1472. doi: 10.3390/ijms18071472.

43.

A case of Alagille syndrome presenting with chronic cholestasis in an adult.

Kim J, Yang B, Paik N, Choe YH, Paik YH.

Clin Mol Hepatol. 2017 Sep;23(3):260-264. doi: 10.3350/cmh.2016.0057. Epub 2017 Jul 7.

44.

Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.

Paik N, Sinn DH, Lee JH, Oh IS, Kim JH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Liver Int. 2018 Jan;38(1):68-75. doi: 10.1111/liv.13489. Epub 2017 Jul 3.

PMID:
28581248
45.

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B.

Sohn W, Cho JY, Kim JH, Lee JI, Kim HJ, Woo MA, Jung SH, Paik YH.

Clin Mol Hepatol. 2017 Jun;23(2):170-178. doi: 10.3350/cmh.2016.0086. Epub 2017 May 16.

46.

[The Clinical Significance of Serum Alpha-fetoprotein in Diagnosing Hepatocellular Carcinoma in a Health Screening Population].

Ko YS, Bae JH, Sinn DH, Gwak GY, Kang W, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Korean J Gastroenterol. 2017 Apr 25;69(4):232-238. doi: 10.4166/kjg.2017.69.4.232. Korean.

47.

Epsilon-Q: An Automated Analyzer Interface for Mass Spectral Library Search and Label-Free Protein Quantification.

Cho JY, Lee HJ, Jeong SK, Paik YK.

J Proteome Res. 2017 Dec 1;16(12):4435-4445. doi: 10.1021/acs.jproteome.6b01019. Epub 2017 Apr 4.

PMID:
28299940
48.

The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE.

Kim JH, Sinn DH, Shin SW, Cho SK, Kang W, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Choi MS.

Clin Mol Hepatol. 2017 Mar;23(1):42-50. doi: 10.3350/cmh.2016.0058. Epub 2017 Mar 7.

49.

Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.

Cho JY, Choi MS, Lee GS, Sohn W, Ahn J, Sinn DH, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW.

Clin Mol Hepatol. 2016 Dec;22(4):477-486. doi: 10.3350/cmh.2016.0048. Epub 2016 Dec 25.

50.

Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.

Kim JH, Sinn DH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Hepatology. 2017 Aug;66(2):335-343. doi: 10.1002/hep.28916. Epub 2016 Dec 24.

PMID:
28012257

Supplemental Content

Support Center